Status:
COMPLETED
Evaluation of the DPP II Assay in Laos
Lead Sponsor:
Foundation for Innovative New Diagnostics, Switzerland
Conditions:
Acute Febrile Illness
Eligibility:
All Genders
12+ years
Brief Summary
Fever is the most frequent symptom in patients seeking care globally. Several causative agents of febrile illness have been described with a high prevalence in South East Asia. They include malaria, d...
Eligibility Criteria
Inclusion
- Participants \> 12 years old enrolled in the "Prospective study of the causes of fever amongst patients admitted to Mahosot Hospital, Vientiane, Lao PDR" (UI-2 study).
- Fever (≥ 37.5 °C)
- Illness duration \< 14 days
- Willingness to provide blood samples by venepuncture
Exclusion
- Absence of consent (and assent for children) to participate to the "Prospective study of the causes of fever amongst patients admitted to Mahosot Hospital, Vientiane, Lao PDR" (UI-2 study).
- Non-infectious known or suspected cause of fever
- No left over blood sample or insufficient volume of left over sample
Key Trial Info
Start Date :
November 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04299607
Start Date
November 12 2019
End Date
November 30 2020
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LOMWRU, Mahosot Hospital
Vientiane, Laos